Credit Carryover

Credit carryover in the Pennsylvania R&D tax credit framework signifies the statutory right of a taxpayer to preserve unused incentive amounts for application against qualified tax liabilities in future periods. Under current Commonwealth law, these credits may be carried forward for a maximum of fifteen taxable years to offset Corporate Net Income Tax or Personal Income Tax liabilities.

The evolution of the Pennsylvania Research and Development (R&D) Tax Credit, codified under Article XVII-B of the Tax Reform Code of 1971, reflects a sustained legislative commitment to fostering an environment of industrial innovation and technological advancement within the Commonwealth. Initially established by Act 7 of 1997, the credit serves as a primary fiscal incentive for taxpayers engaged in qualified research activities, providing a mechanism to offset significant portions of their state tax burden based on incremental increases in research spending. The architecture of the Pennsylvania credit is distinct from its federal counterpart under Internal Revenue Code (IRC) Section 41, particularly in its treatment of credit carryover, its lack of refundability, and its unique provisions for the sale and assignment of unused credits in a secondary market.

Statutory Foundations and the Legislative Intent of Article XVII-B

The legislative intent behind the R&D tax credit is explicitly defined by the Department of Revenue (DOR) as a tool to encourage taxpayers to increase research expenditures within Pennsylvania, thereby enhancing the state’s economic growth and competitiveness. By offering a non-refundable credit that rewards spending above a historical baseline, the Commonwealth incentivizes companies to not only maintain their current R&D footprint but to expand it progressively year over year.

The permanence of the program was secured via Act 85 of 2016, which repealed the sunset provision that had previously shadowed the credit’s long-term utility. This legislative stability is paramount for the carryover mechanism; without the guarantee of the program’s continuity, the statutory fifteen-year carryforward period would be functionally undermined by the risk of credit expiration due to legislative termination. Consequently, corporate financial planners and tax directors can treat these carryover credits as reliable deferred tax assets, subject to the valuation and utilization rules established by the Department of Revenue and the Department of Community and Economic Development (DCED).

Defining Credit Carryover and the Qualified Tax Liability

A carryover occurs when the amount of an awarded R&D tax credit exceeds the taxpayer’s qualified tax liability for the tax year in which the credit was approved. Because the Pennsylvania R&D tax credit is non-refundable, the Commonwealth does not issue cash payments for the unused portion of the credit. Instead, the law permits the taxpayer to “carry over” this excess to succeeding taxable years to be applied against future liabilities.

The Fifteen-Year Carryforward Window

Section 1704-B of the Tax Reform Code specifies that the R&D tax credit may be carried over and applied to succeeding taxable years for no more than fifteen taxable years following the first taxable year for which the taxpayer was entitled to claim the credit. This duration is a critical component of the incentive’s value, particularly for capital-intensive industries such as biotechnology and aerospace, where the timeline from research inception to commercial profitability often spans over a decade.

The mechanism for reduction is strictly sequential. Each time the research and development tax credit is carried over, it is reduced by the amount used as a credit during the immediately preceding taxable year. This ensures a transparent accounting of the credit’s remaining “lifetime” and prevents the compounding of credits beyond their statutory expiration.

Prohibition of Carrybacks and Refunds

Unlike certain other tax attributes, the R&D tax credit is explicitly prohibited from being carried back to prior tax years. A taxpayer cannot use a current-year award to seek a refund of taxes paid in previous years. This “forward-only” restriction shifts the economic focus of the credit toward future growth or the immediate monetization of the credit through the Commonwealth’s assignment program.

Analysis of Qualified Tax Liabilities

The utility of a carryover credit is limited by the definition of “Qualified Tax Liability.” Under Section 1702-B, this term encompasses liabilities imposed under the following articles of the Tax Reform Code:

• Article III: Personal Income Tax (PIT), which applies to individuals, sole proprietors, and partners/shareholders of pass-through entities.
• Article IV: Corporate Net Income Tax (CNIT), which is the primary tax liability for C-Corporations operating in the Commonwealth.
• Article VI: Capital Stock and Franchise Tax, which was historical in nature and has since been phased out, but remains relevant for older carryover credits still within their fifteen-year window.

Significantly, the definition of qualified tax liability excludes any tax withheld by an employer from an employee under Article III. This means a company cannot use its R&D credits to satisfy its payroll withholding obligations; the credit must be applied against the entity’s or its owners’ direct income tax burdens.

State Revenue Office Guidance: Restricted Tax Credit Bulletin 2024-01

The Department of Revenue provides authoritative guidance on the application of these credits through administrative bulletins. Restricted Tax Credit Bulletin 2024-01, issued on March 20, 2024, outlines the operational protocols for “restricted” credits, a category that includes the R&D tax credit.

The Priority of Credit Application

One of the most consequential rules established in Bulletin 2024-01 is the hierarchy of payment. The Department stipulates that all restricted credits, whether they were originally approved for the taxpayer or acquired through a purchase, must be the first credits applied to a taxpayer’s liability. This mandatory “credit-first” rule ensures that taxpayers maximize the utilization of their credits before any cash payments are applied to their accounts.

This rule has profound implications for corporate treasury and cash management. If a taxpayer has both a carryover R&D credit and has made estimated cash tax payments, the Department will apply the credit to the liability first. This may result in the cash payments becoming an “overpayment,” which can then be refunded to the taxpayer or transferred to satisfy other liabilities. This administrative mechanism effectively provides a route to liquidity for taxpayers who have both credits and cash in their accounts, albeit not through a direct refund of the credit itself.

First-In-First-Out (FIFO) Methodology

The Bulletin further clarifies that when a taxpayer maintains carryover credits from multiple award years, the Department applies these on a First-In-First-Out (FIFO) basis. This approach is inherently taxpayer-friendly, as it ensures that the oldest credits—those closest to their fifteen-year expiration date—are exhausted first. For example, if a taxpayer possesses $50,000 in carryover credits from a 2012 award and $50,000 from a 2023 award, a $60,000 liability in 2024 will first absorb the entire 2012 balance before utilizing $10,000 of the 2023 award.

Application to Estimated Payments

For taxpayers required to make quarterly estimated payments, Bulletin 2024-01 provides specific guidance on how credits can satisfy these obligations. To avoid estimated enforcement interest (underpayment penalties), the credits must be in the taxpayer’s account by the due date of the payment. For buyers of credits, this means the sale must be finalized and the credit transferred before the estimated payment deadline to mitigate interest assessments.

R&D Credit Calculation and the Incremental Benefit Model

The Pennsylvania R&D tax credit is calculated as a percentage of “qualified research expenses” (QREs) that exceed a “Pennsylvania base amount”. This incremental model is designed to reward companies for increasing their research investments relative to their historical average.

The Bifurcation of Large and Small Businesses

Pennsylvania law creates two distinct categories for applicants, based on their asset size, which significantly impacts the credit rate and the likelihood of award proration:

1. Small Business: Defined as a for-profit corporation, LLC, partnership, or proprietorship with a net book value of assets totaling less than $5 million at the beginning or end of the taxable year.
2. Large Business (“Not Small”): Any qualifying entity with assets exceeding the $5 million threshold.

Determining the Base Amount

The Pennsylvania base amount is generally modeled after the federal definition in IRC Section 41(c). It represents the average qualified research expenses incurred in Pennsylvania over the four preceding taxable years. For newer companies with fewer than four years of history, the base amount is determined using the number of immediately preceding years available, provided the taxpayer has at least two years of expenditure history to be eligible for the credit.

The credit formula can be expressed as:

Tax Credit = Rate × (Current Year PA QREs – PA Base Amount)

where the Pennsylvania Base Amount cannot be less than 50% of the current year’s Pennsylvania QREs.

The Secondary Market: Sale and Assignment of Carryover Credits

One of the most innovative features of the Pennsylvania R&D tax credit is the Assignment Program, which allows technology-oriented companies to sell their unused credits to other Pennsylvania taxpayers. This program is particularly vital for early-stage companies that are conducting intensive research but have not yet generated sufficient taxable income to utilize their credits.

The One-Year Holding Period

Revenue office guidance, specifically from the DCED, stipulates that a taxpayer must hold the R&D tax credit for at least one year after the date of approval before it can be sold or assigned. This requirement ensures that the original recipient has at least one full tax cycle to apply the credit against their own liabilities. For example, a credit approved on December 15, 2023, is first eligible for assignment on December 15, 2024.

Restrictions on Purchasers and Assignees

While the original taxpayer enjoys a fifteen-year carryover period and can offset 100% of their liability with their own credits, the purchaser of a credit is subject to significant statutory restrictions. According to Section 1704-B(e) and Bulletin 2024-01:

1. Immediate Claim: The purchaser must claim the credit in the taxable year in which the purchase or assignment is made.
2. No Carryover or Carryback: The purchaser is prohibited from carrying the credit forward to future years or back to previous years. Any unused portion of a purchased credit expires at the end of the purchase year.
3. No Secondary Sales: A purchaser may not resell or further assign the credit to another party.
4. 75% Offset Limit: A purchaser may not use the acquired credit to offset more than 75% of their qualified tax liability for the year.

These restrictions create a market dynamic where credits are typically sold at a discount (often between 85% and 92% of face value) to compensate the buyer for the lack of flexibility and the 25% cash tax requirement.

Table: Comparison of Credit Rights (Originator vs. Purchaser)

Pass-Through Entities and Individual Carryover Rules

For Pennsylvania S-Corporations, Partnerships, and Limited Liability Companies (LLCs) treated as partnerships, the R&D credit is calculated at the entity level but is utilized by the individual owners.

Proportional Transfer to Owners

If a pass-through entity cannot use the full credit due to insufficient tax liability at the entity level (where applicable) or chooses to pass the benefit through, it can transfer portions of the credit to its shareholders, members, or partners. This transfer must be proportional based on the owner’s ownership interest in the entity.

For these individual taxpayers, the credit is applied against their Personal Income Tax (PIT) liability. Under Bulletin 2024-01, restricted credits for PIT purposes are applied after the application of the Tax Forgiveness Credit and the Resident Credit for taxes paid to other states.

Restrictions on Passed-Through Credits

Once a credit has been passed through to a partner, member, or shareholder, several restrictions apply to ensure the credit is not “trapped” or inappropriately monetized at the individual level:

• No Second Pass-Through: A credit cannot be passed a second time to a parent’s shareholders if the recipient is itself a pass-through entity.
• Carryforward at Individual Level: Unused credits passed through to individuals generally retain the remainder of the original fifteen-year carryforward period, provided they remain in the individual’s account.
• No Sale by Individuals: Once a credit is passed through to an owner, it generally cannot be sold or assigned on the open market; the sale must typically occur at the entity level before the pass-through election is finalized.

Administrative Compliance: The myPATH System and Deadlines

The administration of the R&D tax credit has transitioned to the Department of Revenue’s online filing system, myPATH. This platform is the mandatory portal for all applications, status tracking, and subsequent requests for sale or assignment.

The Annual Application Cycle

Participation in the R&D credit program requires a timely annual application. The window typically opens on August 1 and closes on December 1. This deadline is for expenditures incurred during the taxable year that ended in the prior calendar year. For a calendar-year taxpayer, 2023 expenses must be submitted by December 1, 2024.

Failure to meet the December 1 deadline results in the denial of the credit for that expenditure year. All timely filed applications are reviewed simultaneously, which allows the Department to determine if the $60 million annual cap will be exceeded and to calculate the necessary proration for “not small” businesses.

Tax Clearance and Compliance Requirements

Act 43 of 2017 authorized the Department of Revenue to perform rigorous tax clearances on all applicants prior to awarding any credits. To be eligible for an award or to carry over/sell existing credits, the taxpayer must be in full compliance with all state tax reporting and payment requirements.

Compliance checks include:

• Filing of all required tax reports for the taxable year in which the expenses were approved.
• Payment of any outstanding balances of state tax due as determined at settlement, assessment, or determination by the Department.
• Compliance by any person or business with 20% or greater ownership in the entity.

If a taxpayer is deemed non-compliant, the Department will issue a correspondence requesting the resolution of the outstanding issues. Failure to respond promptly will result in the denial of the application or the sale request.

Analysis of Qualified Research Activities (The Four-Part Test)

To be eligible for the credit and any subsequent carryover, the research activities must meet the federal definition of “qualified research” under IRC Section 41(d), which Pennsylvania has adopted. The myPATH application requires detailed narratives addressing each component of the “Four-Part Test”:

1. Elimination of Uncertainty: The taxpayer must describe in detail how they attempted to eliminate uncertainty regarding the development or improvement of a product or process.
2. Process of Experimentation: A detailed evaluation of alternatives is required, including methods such as modeling, simulation, or systematic trial and error.
3. Technological in Nature: The process must rely on principles of the physical or biological sciences, engineering, or computer science.
4. Qualified Purpose: The research must be intended to create a new or improved product or process that results in increased performance, function, reliability, or quality.

Economic Context: Proration and Program Utilization

Because the R&D Tax Credit is capped at $60 million annually, the program is frequently oversubscribed, particularly in the “not small” business pool.

Proration Trends

In recent program years, large businesses have seen their tentative credit awards significantly reduced through proration to stay within the $48 million allocation for that group. In 2024, the proration rate for “not small” businesses was approximately 41.1%. In contrast, small businesses, which are earmarked $12 million, often receive 100% of their tentative requests because the total requests from that sector often fall below the set-aside amount.

This creates a disparity in carryover potential. A small business with $100,000 in qualifying excess expenditures would receive a $20,000 credit (20% rate). A large business with the same $100,000 in excess expenditures would calculate a $10,000 tentative credit (10% rate), but might only be awarded $4,110 after proration. This significantly impacts the long-term tax planning for the large business, as their carryover pool is smaller than the initial calculation would suggest.

Sector-Specific Utilization

Data from the 2024 and 2025 R&D reports indicate that the Information sector receives the largest amount of R&D tax credit per recipient, with over 80% of those awards going to firms in streaming services, social media, data processing, and web hosting. These sectors often generate high carryover balances due to the recurring nature of software development and the delay in achieving profitability relative to their intensive initial research investments.

Impact of Federal Tax Law Changes (IRC Section 174)

The value and utility of Pennsylvania R&D credit carryovers have been impacted by federal changes introduced by the Tax Cuts and Jobs Act (TCJA). Historically, businesses could immediately expense R&D costs under IRC Section 174. However, starting in 2022, these costs must be capitalized and amortized over five years for domestic research.

While Pennsylvania does not automatically conform to federal immediate expensing (and requires its own amortization treatment), the federal requirement to capitalize R&D expenses can increase a company’s federal taxable income. Because Pennsylvania’s Corporate Net Income Tax is based on federal taxable income (with specific state-level modifications), this change has the effect of increasing the state tax liability for many innovative firms.

Paradoxically, this increased liability can be beneficial for the utilization of R&D credit carryovers. A company that previously had no tax liability (and thus was carrying over all its credits) may now find itself with a tax bill that can be offset by those very credits. This highlights the importance of integrating federal and state tax timing into a cohesive long-term strategy.

Interaction with Other Pennsylvania Tax Incentives

Carryover credits do not exist in a vacuum; they interact with other state programs that may reduce or eliminate tax liability, thereby extending the life of the carryover.

Keystone Opportunity Zones (KOZ)

The Keystone Opportunity Zone program provides virtually tax-free status to businesses operating within designated zones. If a taxpayer is located in a KOZ, their state tax liability may be zero, which would prevent them from utilizing any R&D credits. In such cases, the R&D credit must be carried over to future years when the KOZ status expires, or the company must seek to sell the credits on the secondary market.

Net Operating Losses (NOLs)

Pennsylvania law regarding the carryforward of Net Operating Losses has undergone significant changes via Act 53 of 2022 and SB 654 of 2024. The limit on how much taxable income can be offset by NOLs is gradually increasing from 40% to 80% through 2029.

This schedule is critical for R&D credit carryover planning. Because credits are typically applied to the remaining liability after other deductions, the availability of NOLs to offset income directly affects the “capacity” of the taxpayer to use an R&D credit. If a company uses NOLs to reduce its taxable income by 40%, the R&D credit carryover is then applied against the tax on the remaining 60% of income.

Comprehensive Multi-Year Example: The Lifecycle of a Credit

To illustrate the interplay of all these rules, consider the case of “Keystone Photonics,” a Pennsylvania-based hardware developer.

Year 0-2: Establishment and Eligibility

Keystone Photonics is founded in 2022. It incurs R&D expenses in 2022 and 2023. Under the law, it must have at least two years of expenditures to be eligible for the credit.

Year 3: First Credit Application (Small Business)

In 2024, Keystone Photonics applies for a credit based on its 2023 expenses.

• Assets: $3 million (Qualified Small Business).
• 2023 QREs: $500,000.
• Base Amount: $300,000.
• Tentative Credit: 20% of ($500,000 – $300,000) = $40,000.
• Award: The small business pool is not oversubscribed, so it is awarded the full $40,000 on May 1, 2025.

Year 4: Carryover and FIFO Application

In 2025, Keystone generates its first taxable income, resulting in a CNIT liability of $10,000.

• Utilization: The 2024 award is applied first to the $10,000 liability.
• Carryover: $30,000 remains in the carryover pool.
• Expiration: This $30,000 will expire at the end of tax year 2039 (15 years from 2024).

In 2025, Keystone also receives a new credit award for its 2024 expenses, totaling $15,000.

Year 5: Growth and Sale

In 2026, Keystone’s assets grow to $6 million. It is now a “large business”.

It has no tax liability in 2026 due to an expansion into a new facility.

• Credit Pool: $30,000 (from 2024 award) and $15,000 (from 2025 award).
• Monetization: Keystone decides to sell the $30,000 carryover credit to raise cash for equipment.
• Requirement: Since the 2024 award was approved more than one year ago (May 2025), it is eligible for sale in 2026.
• Sale: It sells the $30,000 credit to “Steel City Logistics” for $27,000 (90% value).

Year 6: Purchaser Utilization

Steel City Logistics has a 2026 tax liability of $100,000.

• Restriction: As a purchaser, it can only offset 75% of its liability ($75,000).
• Application: It applies the full $30,000 purchased credit, leaving a $70,000 cash tax bill.
• Finality: Steel City must use the credit in 2026; it cannot carry over any unused portion.

Audit and Record Retention Strategies

To protect the value of carryover credits, taxpayers must implement robust documentation systems. The Department of Revenue often conducts audits years after the initial credit was awarded, particularly when a carryover is finally applied against a large liability.

Technical Documentation

Companies should maintain project-specific files that include:

• Iterative design documents showing the “Process of Experimentation”.
• Meeting minutes or lab notebooks detailing the technical challenges and “Elimination of Uncertainty”.
• Clear links between technical milestones and the scientific personnel involved.

Financial Documentation

The audit trail for QREs must be impeccable:

• Wages: Payroll reports showing the percentage of time each employee spent on qualified research.
• Supplies: Invoices for materials consumed in the research process, excluding capital equipment.
• Contract Research: 1099-MISC/W-2 forms and contracts for third-party R&D providers, ensuring that only 65% of these costs are claimed.
• Computer/Cloud Costs: Detailed billing for cloud platforms used specifically for development and testing environments.

Future Outlook for the Pennsylvania R&D Incentive

The current legislative environment in Pennsylvania suggests a continued focus on expanding innovation zones and increasing the efficiency of tax credit administration. While the program cap is currently fixed at $60 million through June 30, 2025, there is consistent advocacy for increasing this limit to reduce proration and provide more predictable benefits to the state’s burgeoning technology sector.

Furthermore, the Department of Revenue continues to refine the myPATH portal to streamline the application and transfer processes. The introduction of the New Online Petition Center for appeals in 2024 provides taxpayers with a more robust mechanism to challenge the denial of credits or the determination of qualified research expenses, further enhancing the stability and reliability of the carryover incentive.

Final Thoughts

The Pennsylvania R&D tax credit carryover is a versatile and valuable fiscal asset, but its utility is highly dependent on proactive management and adherence to strict administrative guidelines. Taxpayers should view the credit not as a static reduction in tax, but as a dynamic financial instrument.

To maximize the impact of the carryover, firms should:

1. Prioritize Small Business Status: Carefully monitor asset levels to stay below the $5 million threshold, which doubles the credit rate and virtually eliminates the risk of award proration.
2. Maintain Multi-Year Baselines: Consistent tracking of PA-specific QREs is essential for calculating the base amount and ensuring the accuracy of the incremental credit calculation.
3. Optimize Liquidity through Timing: Businesses should evaluate their projected tax liabilities over the fifteen-year carryover window. If current liabilities are low and capital needs are high, the one-year holding period for the assignment program should be built into the company’s fundraising or capital expenditure timeline.
4. Adhere to FIFO Accounting: Ensure that the corporate tax ledger reflects the Department’s FIFO methodology to prevent the inadvertent expiration of older credits.
5. Coordinate with Federal Strategy: Account for the impact of federal amortization rules on state taxable income to accurately project the “capacity” for credit utilization.

By weaving these regulatory nuances into their broader corporate strategy, Pennsylvania businesses can ensure that their innovation efforts are fully supported by the Commonwealth’s statutory incentive structure, securing both immediate fiscal benefits and long-term economic resilience.